---
title: "Ramaswamy's Axovant Alzheimer drug fails, stock crashes 75% after pump-and-dump"
date: 2017-09-26
importance: 8
draft: false

tags:
  - vivek-ramaswamy
  - financial-fraud
  - pump-and-dump
  - axovant
  - roivant
  - pharmaceutical
  - investor-fraud

actors:
  - Vivek Ramaswamy
  - Axovant Sciences
  - Roivant Sciences
  - GlaxoSmithKline

verification_status: "pending"
last_updated: 2025-10-18T00:46:42Z
---

Vivek Ramaswamy's Axovant Sciences announced its Alzheimer's drug intepirdine failed clinical trials, causing the stock to crash 75% in one day from $200 to eventually 40 cents. Ramaswamy had sold $40 million of his personal stake at the peak while hyping the drug in media. The drug had already failed four GlaxoSmithKline trials before Axovant bought it for $5 million, fleecing thousands of retail investors in what critics called a pump-and-dump scheme.

## Sources

1. [Vivek Ramaswamy Is a Fraudâ€”and Always Has Been](https://www.newsweek.com/vivek-ramaswamy-fraud-always-has-been-opinion-1823853)
2. [Billionaire Vivek Ramaswamy is a Wall Street speculator accused of pump-and-dump schemes](https://geopoliticaleconomy.com/2024/12/27/vivek-ramaswamy-wall-street-pump-and-dump/)
3. [Vivek Ramaswamy's push for FDA changes could boost his wealth](https://www.washingtonpost.com/business/2024/11/25/vivek-ramaswamy-conflicts-doge-fda/)

---

**Last Updated**: October 18, 2025
**Importance Score**: 8/10
